Autophagy

How macroautophagy assembles

Macroautophagy — the form most people mean by "autophagy" — builds a temporary double-membrane organelle around the cargo, ships it to the lysosome, and digests both cargo and inner membrane. The five-stage choreography:

1. Initiation. The ULK1 complex (ULK1-ATG13-FIP200-ATG101) is held inactive by mTORC1 phosphorylation. Starvation, AMPK signaling, or rapamycin treatment turns ULK1 on. Activated ULK1 phosphorylates downstream ATG proteins and recruits the class-III PI3K complex (Beclin-1-VPS34-VPS15-ATG14L) to a discrete membrane site, often the ER.
2. Nucleation. The PI3K complex generates PI3P at the omegasome, attracting WIPI proteins. A cup-shaped phagophore (isolation membrane) emerges, drawing lipid from the ER, mitochondria, plasma membrane, and recycled ATG9 vesicles.
3. Elongation. Two ubiquitin-like conjugation cascades extend and seal the phagophore. ATG12-ATG5-ATG16L1 forms one E3-ligase-like complex. LC3, processed by ATG4 to expose a C-terminal Gly, is activated by ATG7, transferred via ATG3, and conjugated to phosphatidylethanolamine on the membrane — yielding LC3-II, the standard autophagy marker.
4. Cargo capture. Selective receptors (p62/SQSTM1, NBR1, OPTN, NDP52) bridge ubiquitinated cargo to LC3-II via LIR motifs. Bulk autophagy captures cytosol indiscriminately during starvation; selective autophagy targets specific organelles or aggregates.
5. Closure and fusion. The phagophore seals into a closed double-membrane autophagosome. SNAREs and tethering complexes (HOPS) drive fusion with a lysosome. Acid hydrolases degrade the inner membrane and cargo. Amino acids, fatty acids, and sugars are exported back to the cytosol.

The whole cycle takes 10-20 minutes per autophagosome in starved cultured cells. A single fasted hepatocyte can run dozens in parallel.

Why autophagy matters

• Survival in starvation. Newborn mice die hours after birth without autophagy because they cannot recycle amino acids before suckling begins (Kuma et al., 2004).
• Organelle quality control. Mitophagy, ER-phagy, ribophagy, and lipophagy clear damaged or surplus organelles; failure causes neurodegeneration and metabolic disease.
• Innate immunity (xenophagy). Autophagy degrades intracellular bacteria — Salmonella, group A Streptococcus, Mycobacterium — and many pathogens evolve evasion strategies.
• Antigen presentation. Cytosolic autophagy delivers viral and self-antigens to MHC class II, supplementing the canonical phagosome route.
• Aging and longevity. Caloric restriction and rapamycin extend lifespan in yeast, worms, flies, and mice; both act partly through autophagy induction.
• Tumor biology. Tumor-suppressive in early lesions, tumor-supporting in established tumors — context-dependent.
• Drug development. Autophagy modulators (rapamycin, hydroxychloroquine, spermidine, urolithin A) are in trials across oncology, neurology, and cardiology.

Forms of autophagy

Form	Mechanism	Cargo	Distinguishing markers	Notes
Macroautophagy	Double-membrane autophagosome engulfs cargo, fuses with lysosome	Bulk cytosol; organelles; aggregates; pathogens	LC3-II, ATG5-12, p62	The default referent of "autophagy"
Microautophagy	Lysosomal membrane directly invaginates and pinches off cargo	Soluble proteins, small organelles	ESCRT machinery; Hsc70	Less well-characterized in mammals; clear in yeast
Chaperone-mediated autophagy (CMA)	Hsc70 + KFERQ motif → LAMP2A oligomer translocates substrate directly	Soluble cytosolic proteins (~30% of proteome)	LAMP2A levels; KFERQ-tagged substrates	Declines with aging; relevant to Parkinson's α-synuclein clearance
Mitophagy	Selective macroautophagy of mitochondria via PINK1-Parkin or BNIP3/NIX	Damaged or surplus mitochondria	PINK1 stabilization; phospho-Ub; OPTN, NDP52	Loss causes early-onset Parkinson's
Aggrephagy	Selective macroautophagy of protein aggregates	Polyubiquitinated misfolded protein clumps	p62, NBR1, TAX1BP1	Critical in Huntington's, ALS, frontotemporal dementia
Xenophagy	Selective macroautophagy of intracellular pathogens	Cytosol-invading bacteria, viruses	Galectin-8, NDP52, p62	Pathogens evolve LC3 lipase mimics or escape mechanisms
Lipophagy	Macroautophagy of lipid droplets	Triglycerides, cholesterol esters	LD-resident Plin proteins; Rab7	Discovered 2009; major in liver fasting biology

The core ATG machinery

Stage	Yeast (ATG)	Mammalian	Function
Induction	Atg1, Atg13, Atg17	ULK1/2, ATG13, FIP200, ATG101	Serine/threonine kinase complex; integrates mTOR/AMPK input
Nucleation (PI3K)	Vps34, Vps15, Atg6, Atg14	VPS34, VPS15, Beclin-1, ATG14L	Generates PI3P at omegasome
Membrane source	Atg9	ATG9A	Only transmembrane ATG protein; shuttles lipid in vesicles
Elongation E1/E2/E3 (ATG12 conjugation)	Atg7, Atg10, Atg5-Atg12-Atg16	ATG7, ATG10, ATG5-ATG12-ATG16L1	Ubiquitin-like cascade; sets up the LC3 conjugation site
LC3/Atg8 conjugation to PE	Atg4, Atg7, Atg3, Atg8	ATG4 (A-D), ATG7, ATG3, LC3 (A/B/C), GABARAP	Anchors LC3 to membrane; recruits cargo receptors
Selective cargo	Atg19, Atg11	p62/SQSTM1, NBR1, OPTN, NDP52, TAX1BP1	LIR + UBD bridges; couple ubiquitin to LC3
Fusion with lysosome	Vps41, Ypt7	HOPS complex, RAB7, syntaxin-17, SNAP29, VAMP8	Tethering and SNARE-mediated fusion

Real-world consequences

• Newborn lethality. Atg5-knockout mice die within a day of birth from amino acid insufficiency before suckling can supply nutrients — direct evidence that autophagy is essential for the perinatal starvation gap.
• Parkinson's disease. Loss-of-function mutations in PINK1 or PARK2 (Parkin) prevent mitophagy and cause autosomal-recessive early-onset Parkinson's. Damaged mitochondria accumulate in dopaminergic neurons.
• Cancer. BECN1 is monoallelically deleted in 40-75% of breast, ovarian, and prostate cancers. Yet established Ras-driven tumors become "autophagy-addicted" — hydroxychloroquine, an autophagy inhibitor, has shown modest activity in pancreatic cancer trials.
• Crohn's disease. ATG16L1 T300A is a major risk allele; the variant blunts xenophagic clearance of intracellular bacteria in Paneth cells and disrupts antimicrobial granule biology.
• Rapamycin and longevity. Rapamycin (mTOR inhibitor) extends lifespan in mice across multiple strains and dosing regimens. Its anti-aging effects are partly autophagy-dependent.
• Protein aggregation diseases. Huntingtin polyQ aggregates, mutant α-synuclein, and TDP-43 inclusions are normally cleared by aggrephagy. Genetic or pharmacological enhancement of autophagy reduces pathology in animal models.
• Pathogen evasion. Listeria uses ActA to coat itself and avoid xenophagy; Shigella deploys IcsB; Legionella blocks LC3 lipidation with the protease RavZ. Each evolved a custom defeat for the same machinery.

Variants and special cases

• Selective autophagy receptors. p62 binds polyubiquitin via UBA + LC3 via LIR. NDP52 and OPTN are antibacterial. NBR1 cooperates with p62. Each receptor selects different cargo classes.
• Non-canonical LC3 lipidation (CASM/LAP). LC3-associated phagocytosis lipidates LC3 onto single-membrane phagosomes — same conjugation cascade, different organelle. Important in immune cells.
• Reticulophagy. ER-phagy via FAM134B, RTN3, and SEC62 receptors clears damaged ER tubules and sheets — relevant to neuropathy and ER stress responses.
• Pexophagy. Selective peroxisome turnover via NBR1 and PEX14 — particularly active when cells transition between fatty-acid and glucose substrates.
• Secretory autophagy. Autophagosomes can fuse with the plasma membrane instead of lysosomes, releasing IL-1β, mucins, and other unconventional cargo without classical ER-Golgi traffic.
• ATG5/ATG7-independent ('alternative') autophagy. A back-up pathway uses RAB9 and the trans-Golgi to engulf cargo when canonical ATG conjugation is genetically disabled. Discovered in mouse erythroid maturation.

Common pitfalls and misconceptions

• "More LC3-II = more autophagy." Not necessarily. LC3-II rises both when synthesis goes up and when degradation slows. Bafilomycin A1 'flux assays' (with vs. without lysosomal blockade) are needed to distinguish induction from blockade.
• "Autophagy is always cytoprotective." Sustained or runaway autophagy can drive autophagic cell death (Type II programmed death), particularly when apoptosis is blocked.
• "Fasting flips autophagy on like a switch in humans." Rodent data are clean; human data are inconsistent and mostly correlative. The dose-response of fasting duration to autophagy in humans is poorly characterized.
• "All autophagy uses LC3." Alternative autophagy is ATG5/ATG7/LC3-independent and uses RAB9 instead.
• "Autophagy is the same as the ubiquitin-proteasome system." Both degrade proteins, but the proteasome handles short-lived soluble substrates (one molecule at a time, ATP-dependent unfolding); autophagy handles long-lived proteins, aggregates, and whole organelles via the lysosome.
• "Mitophagy clears any damaged mitochondrion." The PINK1-Parkin axis dominates in stressed conditions, but receptor-mediated mitophagy (BNIP3, NIX, FUNDC1) operates during physiological remodeling such as red-blood-cell maturation and hypoxia.